Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2

Status

Completed 3Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1Genitourinary 1

Conditions

Hematologic Neoplasms 2Stomatitis 1Graft vs Host Disease 1Carcinoma, Renal Cell 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Transplantation Conditioning × Clear all
NCT01516593 2022-08-04

CARMEN

IRCCS San Raffaele

Phase 2 Completed
19 enrolled
Lymphoid

Burkitt Lymphoma

NCT00189488 2014-09-15

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

Swedish Orphan Biovitrum

Phase 2 Completed
155 enrolled 19 charts
Other hematologic neoplasm

Graft vs Host Disease, Stomatitis, Hematologic Neoplasms

NCT00693927 2011-09-02

Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)

University of Liege

Phase 2 Completed
54 enrolled
GenitourinaryOther hematologic neoplasm

Carcinoma, Renal Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡